1. Muscle loss phenotype in COPD is associated with adverse outcomes in the UK Biobank
- Author
-
Amy H. Attaway, Rocio Lopez, Nicole Welch, Annette Bellar, Umur Hatipoğlu, Joe Zein, Marielle PKJ Engelen, and Srinivasan Dasarathy
- Subjects
Cachexia ,Chronic obstructive pulmonary disease ,Epidemiology ,Sarcopenia ,Skeletal muscle loss ,Diseases of the respiratory system ,RC705-779 - Abstract
Abstract Background Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disorder with systemic consequences that can cause a muscle loss phenotype (MLP), which is characterized by the loss of muscle mass, muscle strength, or loss of both muscle and fat mass. There are limited data comparing the individual traits of MLP with clinical outcomes in a large unbiased cohort of COPD patients. Our aim was to determine the proportion of patients who met criteria for MLP in an unbiased sample of COPD patients at the population-level. We also determined if specific MLP features were associated with all-cause and COPD-related mortality. Methods A retrospective population-based cohort analysis of the UK Biobank was performed. COPD was defined by a FEV1/FVC ratio
- Published
- 2024
- Full Text
- View/download PDF